Corticosteroid and growth hormone responses to methylamphetamine in depressive illness
Author:
- 1 February 1979
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 9 (1) , 107-115
Abstract
SYNOPSIS: It is suggested that, if depressed patients have deficient noradrenergic function at central α-adrenergic receptors, then they will also have impaired corticosteroid responses to methylamphetamine but unaltered growth hormone responses. This prediction has been confirmed when the responses of a group of patients with endogenous depression were compared with the responses of a group of patients with other functional psychoses, a group of patients with reactive depression, and a group of patients with other psychiatric diagnoses. These findings support the hypothesis that there is a functional deficiency of noradrenaline at some central α-adrenergic receptors.Keywords
This publication has 38 references indexed in Scilit:
- Psychologic and Neuroendocrine Response to MethylphenidateArchives of General Psychiatry, 1977
- Effect of emotional stress on human growth hormone secretionJournal of Psychosomatic Research, 1977
- Reduced Growth Hormone Responses to Amphetamine in "Endogenous" Depressive PatientsArchives of General Psychiatry, 1976
- Human Growth Hormone Response to LevodopaArchives of General Psychiatry, 1975
- Effect of illness on serum growth hormone response to intravenous glucoseJournal of Chronic Diseases, 1975
- The Growth Hormone Response to Insulin Induced Hypoglycemia in Anorexia Nervosa and Control Underweight or Normal SubjectsEuropean Journal of Clinical Investigation, 1975
- Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatmentPsychopharmacology, 1975
- Growth Hormone Responses to Hypoglycemia in Postmenopausal Depressed WomenArchives of General Psychiatry, 1975
- Blockade of intravenous amphetamine euphoria in manClinical Pharmacology & Therapeutics, 1971
- Potentiation and blockade of the central action of amphetamine by chlorpromazineBiochemical Pharmacology, 1968